| 000 | 01217 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250518023606.0 | ||
| 264 | 0 | _c20190321 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1873-7560 | ||
| 024 | 7 |
_a10.1016/j.eururo.2018.10.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGratzke, Christian | |
| 245 | 0 | 0 |
_aReply to So-Ryoung Lee, Byoung-Won Park, and Jae Heon Kim's Letter to the Editor re: Christian Gratzke, Rob van Maanen, Christopher Chapple, et al. Long-term Safety and Efficacy of Combined Mirabegron and Solifenacin Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II). Eur Urol 2018;74:501-9. _h[electronic resource] |
| 260 |
_bEuropean urology _c03 2019 |
||
| 300 |
_ae59-e60 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Comment | ||
| 650 | 0 | 4 | _aAcetanilides |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aSolifenacin Succinate |
| 650 | 0 | 4 | _aThiazoles |
| 650 | 0 | 4 | _aUrinary Bladder, Overactive |
| 700 | 1 | _aSiddiqui, Emad | |
| 773 | 0 |
_tEuropean urology _gvol. 75 _gno. 3 _gp. e59-e60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eururo.2018.10.001 _zAvailable from publisher's website |
| 999 |
_c29381527 _d29381527 |
||